The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics and treatment outcomes of patients with pulmonary salivary gland-like tumors.
 
Jonathan Mizrahi
No Relationships to Disclose
 
Pamela Parker Samson
No Relationships to Disclose
 
Siddhartha Hk Devarakonda
No Relationships to Disclose
 
Ashiq Masood
No Relationships to Disclose
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Bayer; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Novartis
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Merck
 
Feng Gao
No Relationships to Disclose
 
Danielle Carpenter
No Relationships to Disclose
 
Cliff Grant Robinson
Stock and Other Ownership Interests - Radialogica
Consulting or Advisory Role - Radialogica
Speakers' Bureau - Varian Medical Systems; ViewRay
Research Funding - Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems; ViewRay
 
Varun Puri
No Relationships to Disclose
 
Daniel Morgensztern
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Heat Biologics
Speakers' Bureau - Boehringer Ingelheim; Genentech
Research Funding - AstraZeneca (Inst); Baxter (Inst); Celgene (Inst); Clovis Oncology (Inst); Heat Biologics (Inst); Incyte (Inst); Merck (Inst); Newlink Genetics (Inst); Stem CentRx (Inst)
 
Saiama Naheed Waqar
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Spectrum Pharmaceuticals (Inst); Synermore biologics (Inst); Vertex (Inst); Xcovery (Inst)